InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Insider track record
OtherDisclosed buys
0
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Explore the full record of transactions filed by Burgess Michael F., Responsable de la Recherche et Développement. Insider active across 2 companies, notably SpringWorks Therapeutics, Inc.. Aggregated, 4 reports have been logged. History available since 1 June 2021. The latest transaction was filed on 18 July 2022 (Retenue fiscale). Regulator: SEC (Form 4). All data is free.
Companies and markets linked to Burgess Michael F.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations4 total
3,103 shares@ US$28.4763.9% of flowCommon StockSEC:0001104659-22-081241:0
2,672 shares@ US$19.6136.1% of flowCommon StockSEC:0001104659-22-077447:0
15,674 sharesCommon StockSEC:0001104659-22-002741:0
27,500 shares0Common StockSEC:0001104659-21-075168:0
4 of 4 declarations
About Burgess Michael F.
Michael F. Burgess is the Head of Research & Development at SpringWorks Therapeutics, Inc. He leads the company's innovation efforts, which focus on developing therapeutic treatments. Burgess plays a crucial role in research strategy, contributing to the advancement of drug development projects. His expertise is vital in ensuring the success of the company's research initiatives.
